status, physical activity, postmenopausal hormone W, pathology use, randomized treatment professionals reports assignment, red meat Intake, smoking status, total energy Age, sex, alcohol Incidence, vs 1.13 ≥398 MCS, consumption, BMI, colon cancer, 543 g/day Prospective Sato, 2005 165/ educational level, energy Cohort, Population COL01930 41 835 Questionnaire content, family history of Midpoints Age: 40-64 registry Incidence, vs 1.12 Japan 7 years ≥398 specific cancer, meat rectal cancer, g/day consumption, physical M activity, smoking status Incidence, vs 0-2.5 0.73 ≥5 colorectal serving/day 0.96) cancer SMC, Incidence, vs 0-2.5 0.81 Prospective 460/ ≥5 Trial, 2001 colon cancer, serving/day 1.13) Cohort, 61 463 COL00059 screening FFQ Age: 40-74 588 270 Incidence, vs 0-2.5 0.60 Sweden ≥5 program years, rectal cancer, serving/day W Incidence, vs 0-2.5 0.91 ≥5 proximal serving/day colon cancer,
W, professionals pathology reports status, physical activity, postmenopausal hormone use, randomized treatment assignment, red meat Intake, smoking status, total energy Sato, 2005 COL01930 Japan MCS, Prospective Cohort, Age: 40-64 M 165/ 41 835 7 years Population registry Questionnaire Incidence, colon cancer, ≥398 vs g/day 1.13 Age, sex, alcohol consumption, BMI, educational level, energy content, family history of specific cancer, meat consumption, physical activity, smoking status Midpoints Incidence, rectal cancer, ≥398 vs g/day 1.12 2001 COL00059 Sweden SMC, Prospective Cohort, Age: 40-74 years, W 460/ 61 463 588 270 screening program FFQ Incidence, colorectal cancer ≥5 vs 0-2.5 serving/day 0.73 Incidence, colon cancer, ≥5 vs 0-2.5 serving/day 0.81 Incidence, rectal cancer, ≥5 vs 0-2.5 serving/day 0.60 Incidence, proximal colon cancer, ≥5 vs 0-2.5 serving/day 0.91 0.96) 1.13) Trial, 543